|                            | Year Ended December 31,   | Year Ended December 31,   | Year Ended December 31,   |
|----------------------------|---------------------------|---------------------------|---------------------------|
|                            | 2024                      | 2023                      | 2022                      |
| Cost of revenue            | $ 1,055                   | $ 740                     | $ 768                     |
| Research and development   | 13,683                    | 11,429                    | 9,361                     |
| Marketing and sales        | 1,026                     | 952                       | 1,004                     |
| General and administrative | 926                       | 906                       | 859                       |
| Total                      | $ 16,690                  | $ 14,027                  | $ 11,992                  |
The following table summarizes the activities for our unvested RSUs for the year ended December 31, 2024:

|                               | Number of Shares (in thousands)   | Weighted-Average Grant Date Fair Value Per Share   |
|-------------------------------|-----------------------------------|----------------------------------------------------|
| Unvested at December 31, 2023 | 149,062                           | $ 209.85                                           |
| Granted                       | 48,661                            | $ 506.80                                           |
| Vested                        | (64,769)                          | $ 250.76                                           |
| Forfeited                     | (10,322)                          | $ 255.04                                           |
| Unvested at December 31, 2024 | 122,632                           | $ 302.27                                           |